Leehey, D.J., Rahman, M.A., Borys, E., Picken, M.M
The most common side effects are mild nausea, reduced appetite, and occasional fatigue particularly in the first few weeks as your body adjusts
The medication acts on appetite centres in the brain, reducing hunger and food intake, which explains its effectiveness for weight management
However, these explorations remain investigational and have not resulted in FDA approval for doses exceeding the 2.4 mg weekly standard for weight management
Mounjaro (tirzepatide) and Retatrutide (semaglutide) are both innovative medications that have shown remarkable success in helping individuals achieve their weight loss goals
The WHO further included rapid-acting insulin analogues, produced by companies such as Novo Nordisk and Eli Lilly, for use in patients with type 1, type 2, and gestational diabetes